Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has been assigned a $86.00 target price by Leerink Swann in a research note issued to investors on Friday. The firm currently has a “buy” rating on the pharmacy operator’s stock. Leerink Swann’s price objective suggests a potential upside of 11.46% from the company’s current price.
Other equities research analysts have also recently issued research reports about the company. Barclays PLC set a $79.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Saturday, April 1st. Jefferies Group LLC restated a “buy” rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Friday, March 31st. Guggenheim restated a “buy” rating and issued a $100.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, April 6th. Pivotal Research set a $85.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Sunday, July 2nd. Finally, Goldman Sachs Group, Inc. (The) restated a “neutral” rating and issued a $77.00 target price (down previously from $89.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, June 28th. Three analysts have rated the stock with a sell rating, three have given a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $90.33.
Walgreens Boots Alliance (WBA) opened at 77.16 on Friday. The company has a 50-day moving average price of $80.89 and a 200-day moving average price of $83.32. The firm has a market cap of $82.57 billion, a P/E ratio of 19.48 and a beta of 1.26. Walgreens Boots Alliance has a 12-month low of $75.18 and a 12-month high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion for the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.18 EPS. On average, analysts predict that Walgreens Boots Alliance will post $5.01 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Monday, June 12th. Investors of record on Thursday, May 18th were issued a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.94%. The ex-dividend date of this dividend was Tuesday, May 16th. Walgreens Boots Alliance’s payout ratio is presently 37.78%.
ILLEGAL ACTIVITY NOTICE: “Walgreens Boots Alliance, Inc. (WBA) Given a $86.00 Price Target by Leerink Swann Analysts” was first reported by WKRB News and is owned by of WKRB News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.wkrb13.com/markets/2286573/walgreens-boots-alliance-inc-wba-given-a-86-00-price-target-by-leerink-swann-analysts.html.
In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Wednesday, May 3rd. The stock was sold at an average price of $85.89, for a total transaction of $234,995.04. Following the transaction, the director now directly owns 21,887 shares of the company’s stock, valued at approximately $1,879,874.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 13.50% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Koshinski Asset Management Inc. raised its position in Walgreens Boots Alliance by 16.6% in the second quarter. Koshinski Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock worth $832,000 after buying an additional 1,515 shares during the last quarter. City Holding Co. raised its position in Walgreens Boots Alliance by 3.2% in the second quarter. City Holding Co. now owns 29,990 shares of the pharmacy operator’s stock worth $2,348,000 after buying an additional 930 shares during the last quarter. Capital One National Association raised its position in Walgreens Boots Alliance by 11.6% in the second quarter. Capital One National Association now owns 3,654 shares of the pharmacy operator’s stock worth $286,000 after buying an additional 379 shares during the last quarter. Stock Yards Bank & Trust Co. raised its position in Walgreens Boots Alliance by 2.4% in the second quarter. Stock Yards Bank & Trust Co. now owns 25,628 shares of the pharmacy operator’s stock worth $2,007,000 after buying an additional 600 shares during the last quarter. Finally, Fox Run Management L.L.C. acquired a new position in Walgreens Boots Alliance during the second quarter worth $1,253,000. 60.63% of the stock is currently owned by institutional investors and hedge funds.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2286573/walgreens-boots-alliance-inc-wba-given-a-86-00-price-target-by-leerink-swann-analysts.html
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.